You are here

  • Home
  • Archive
  • Volume 17, Issue 6
  • Low-molecular-weight heparin prophylaxis does not affect mortality in acutely ill medical patients at low risk for venous thromboembolism

Article Text

Article menu
Download PDFPDF
Electronic pages
Low-molecular-weight heparin prophylaxis does not affect mortality in acutely ill medical patients at low risk for venous thromboembolism

https://doi.org/10.1136/ebmed-2012-100631

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests AS has received lecturing fees, travel support and consultancy fees from Actelion, Bayer, Bristol Myer Squibb, Boehringer Ingelheim, CSL Behring, Novartis, Octapharma, Pfizer and Sanofi Aventis.